LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA

Clinical trials for LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted pill tested for Hard-to-Treat head cancers

Disease control Recruiting now

This study is testing whether a daily pill called enasidenib can help control rare cancers in the nasal cavity and base of the skull. It is for adults whose cancer has a specific genetic change (IDH2 mutation) and has returned or spread after prior treatment. The goal is to see i…

Matched conditions: LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA

Get alerted when new LOCALLY ADVANCED LARGE-CELL NEUROENDOCRINE CARCINOMA trials appear

Targeted pill tested for Hard-to-Treat head cancers